Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

16.57 -2.31 (-12.24%)
Streaming Delayed Price Updated: 2:19 PM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Liquidia Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Pfizer, Vista Outdoor, Duckhorn Portfolio And Other Big Stocks Moving Higher On Monday
Via Benzinga
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
From Liquidia Corporation
Via GlobeNewswire
Evaluating Liquidia: Insights From 14 Financial Analysts
Via Benzinga
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
From Liquidia Corporation
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Liquidia, Napco, and Franklin and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
From Liquidia Corporation
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Is Investigating Paragon 28, Centuri, Liquidia, and Elastic and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
These Analysts Cut Their Forecasts On Liquidia
Via Benzinga
Why Liquidia Corporation Shares Are Moving Lower Monday
Liquidia announced that the Food and Drug Administration granted tentative approval of YUTREPIA. 
Via Benzinga
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
From Liquidia Corporation
Via GlobeNewswire
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
Via Benzinga
Exposures Fossil Fuels
Petco, AppLovin, Dave & Buster's And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
From Liquidia Corporation
Via GlobeNewswire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Liquidia to Present at Upcoming Investor Conferences
From Liquidia Corporation
Via GlobeNewswire
LIQUIDIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Liquidia Corporation (LQDA)
From Kirby McInerney LLP
Via Business Wire
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
From Liquidia Corporation
Via GlobeNewswire
Jim Cramer Praises PayPal CEO Alex Chriss: 'Financial Techs Have Come Back In Style'
PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more. 
Via Benzinga
Palo Alto Networks To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
Via Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
Via Benzinga
Exposures Fossil Fuels
Why Liquidia Stock Just Reversed Its Seven-Day Sprint And Crashed 38%
The company is hoping to launch a drug that rivals United Therapeutics' Tyvaso DPI. 
Via Investor's Business Daily
LQDA Investors Have Opportunity to Join Liquidia Corporation Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
From Liquidia Corporation
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS